Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-25-097007

Options or other derivatives

  • Chief Commercial Officer acquired 51,255 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Friedl-Naderer Johanna Chief Commercial Officer 2025-07-16 Grant or award · Stock option (right to buy) +51,255 51,255 D: show line 1 in the form
Loading xslF345X05/ownership.xml…